期刊
ENDOCRINOLOGY
卷 160, 期 4, 页码 782-790出版社
ENDOCRINE SOC
DOI: 10.1210/en.2018-00985
关键词
-
资金
- National Institutes of Health (NIH) [DK108267]
- NIH National Research Service Award [F32DK116482]
- NIH Training Grant [T32GM007231]
Tamoxifen, a selective estrogen-receptor modulator, is widely used in mouse models to temporally control gene expression but is also known to affect body composition. We report that tamoxifen has significant and sustained effects on glucose tolerance, independent of effects on insulin sensitivity, in mice. IP, but not oral, tamoxifen delivery improved glucose tolerance in three inbred mouse strains. The extent and persistence of tamoxifen-induced effects were sex and strain dependent. These findings highlight the need to revise commonly used tamoxifen-based protocols for gene manipulation in mice by including longer chase periods after injection, oral delivery, and the use of tamoxifen-treated littermate controls.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据